Clinical case: Serpiginous-like choroiditis with macular involvement and good response after treatment with adalimumab.

Autor: Arrieta-Bechara C; IOBA (Instituto de Oftalmobiología Aplicada), Universidad Valladolid, Valladolid, Spain. Electronic address: cesararrietaoftalmologo@gmail.com., Haro-Álvarez B; IOBA (Instituto de Oftalmobiología Aplicada), Universidad Valladolid, Valladolid, Spain., Cocho-Archiles L; IOBA (Instituto de Oftalmobiología Aplicada), Universidad Valladolid, Hospital Universitario de Valladolid, Valladolid, Spain., Herreras Cantalapiedra JM; IOBA (Instituto de Oftalmobiología Aplicada), Universidad Valladolid, Hospital Universitario de Valladolid, Valladolid, Spain.
Jazyk: angličtina
Zdroj: Archivos de la Sociedad Espanola de Oftalmologia [Arch Soc Esp Oftalmol (Engl Ed)] 2022 Aug; Vol. 97 (8), pp. 477-480. Date of Electronic Publication: 2022 Feb 10.
DOI: 10.1016/j.oftale.2021.02.011
Abstrakt: Clinical case of a 42-year-old woman who consulted for decreased vision in the left eye over two months, associated with multifocal choroiditis. Different diagnostic tests were performed to rule out infectious pathologies, as well as a diagnostic vitrectomy test, which was negative. QuantiFERON® was found to be positive and a diagnosis of serpeginous-like choroiditis (SLC) was made. Anti-tuberculosis treatment was started with worsening of vision and multifocal choroiditis. Once conventional immunotherapy and biological treatment were added, the patient presented a significant improvement in vision. To conclude, in cases of CSL, it is not only necessary to treat the infection but also the inflammatory component either with steroids or conventional immunotherapy or immunosuppression with biologics, thus reducing the number of reactivations and improving the visual prognosis.
(Copyright © 2021 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: